Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage.


Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
13 07 2021
Historique:
received: 09 10 2020
revised: 11 03 2021
accepted: 27 04 2021
pubmed: 26 5 2021
medline: 15 9 2021
entrez: 25 5 2021
Statut: ppublish

Résumé

Aging is associated with dysregulated immune functions. Here, we investigated the impact of age on neutrophil diapedesis. Using confocal intravital microscopy, we found that in aged mice, neutrophils adhered to vascular endothelium in inflamed tissues but exhibited a high frequency of reverse transendothelial migration (rTEM). This retrograde breaching of the endothelium by neutrophils was governed by enhanced production of the chemokine CXCL1 from mast cells that localized at endothelial cell (EC) junctions. Increased EC expression of the atypical chemokine receptor 1 (ACKR1) supported this pro-inflammatory milieu in aged venules. Accumulation of CXCL1 caused desensitization of the chemokine receptor CXCR2 on neutrophils and loss of neutrophil directional motility within EC junctions. Fluorescent tracking revealed that in aged mice, neutrophils undergoing rTEM re-entered the circulation and disseminated to the lungs where they caused vascular leakage. Thus, neutrophils stemming from a local inflammatory site contribute to remote organ damage, with implication to the dysregulated systemic inflammation associated with aging.

Identifiants

pubmed: 34033752
pii: S1074-7613(21)00187-4
doi: 10.1016/j.immuni.2021.04.025
pmc: PMC8284598
pii:
doi:

Substances chimiques

Chemokine CXCL1 0
Receptors, Interleukin-8B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1494-1510.e7

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/14/3/30518
Pays : United Kingdom
Organisme : British Heart Foundation
ID : PG/17/85/33395
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 098291/Z/12/Z
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Immunol Rev. 2016 Sep;273(1):48-60
pubmed: 27558327
Cell. 2020 Feb 20;180(4):764-779.e20
pubmed: 32059779
J Clin Invest. 2020 May 1;130(5):2301-2318
pubmed: 31971917
Science. 2012 Jun 29;336(6089):1676-81
pubmed: 22745423
Crit Care Med. 2007 Jan;35(1):246-51
pubmed: 17133178
Expert Rev Respir Med. 2020 Sep;14(9):865-868
pubmed: 32567404
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):385-92
pubmed: 21106704
FEBS Lett. 1998 Jun 23;430(1-2):37-40
pubmed: 9678590
Blood. 2014 Jan 9;123(2):239-48
pubmed: 24191150
J Gerontol A Biol Sci Med Sci. 2014 Jun;69 Suppl 1:S4-9
pubmed: 24833586
Blood. 2013 Jun 13;121(24):4930-7
pubmed: 23645836
BMC Biol. 2017 May 19;15(1):45
pubmed: 28526034
Cell. 2013 Jun 6;153(6):1194-217
pubmed: 23746838
Immunity. 2011 Jun 24;34(6):973-84
pubmed: 21703544
Nat Immunol. 2017 Jul;18(7):753-761
pubmed: 28553950
J Leukoc Biol. 2008 Jun;83(6):1493-501
pubmed: 18319289
Aging Cell. 2004 Aug;3(4):217-26
pubmed: 15268755
Immunity. 2018 Dec 18;49(6):1062-1076.e6
pubmed: 30446388
Nat Rev Cardiol. 2018 Sep;15(9):505-522
pubmed: 30065258
Immunol Rev. 2016 Sep;273(1):76-93
pubmed: 27558329
Science. 2017 Oct 6;358(6359):111-116
pubmed: 28983053
Nat Immunol. 2009 Jan;10(1):101-8
pubmed: 19060902
Nat Immunol. 2011 Jun 26;12(8):761-9
pubmed: 21706006
Anesthesiology. 2012 Jul;117(1):126-36
pubmed: 22634873
Aging Dis. 2012 Jun;3(3):234-47
pubmed: 22724082
Science. 2020 Jul 17;369(6501):256-257
pubmed: 32675364
Immunology. 1999 Oct;98(2):253-7
pubmed: 10540224
Immunol Rev. 2019 May;289(1):205-231
pubmed: 30977203
Nat Rev Immunol. 2016 May 27;16(6):378-91
pubmed: 27231052
Front Immunol. 2012 Aug 17;3:266
pubmed: 22912641
J Clin Invest. 2003 Dec;112(11):1666-77
pubmed: 14660743
Immunity. 2001 Jun;14(6):791-800
pubmed: 11420048
Cell. 2019 Aug 22;178(5):1205-1221.e17
pubmed: 31442408
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Nat Rev Immunol. 2013 Dec;13(12):875-87
pubmed: 24157572
J Immunol. 2008 Apr 1;180(7):4742-53
pubmed: 18354198
J Immunol. 2006 Jan 1;176(1):52-60
pubmed: 16365395
Nat Immunol. 2012 Mar 25;13(5):465-73
pubmed: 22447028
Nat Rev Immunol. 2019 Apr;19(4):255-265
pubmed: 30816340
Annu Rev Immunol. 2020 Apr 26;38:49-77
pubmed: 32340580
Trends Immunol. 2018 Nov;39(11):890-899
pubmed: 30253910
J Immunol. 2012 Sep 15;189(6):2824-32
pubmed: 22869904
J Leukoc Biol. 2006 Dec;80(6):1281-8
pubmed: 16963624
Nat Rev Immunol. 2014 Apr;14(4):232-46
pubmed: 24603165
Trends Immunol. 2018 Feb;39(2):151-162
pubmed: 29196147
Nat Immunol. 2018 Jan;19(1):10-19
pubmed: 29242543
Lancet. 2014 Oct 18;384(9952):1455-65
pubmed: 25390327
Immunity. 2015 Jun 16;42(6):1075-86
pubmed: 26047922
J Tissue Eng. 2014 Dec 20;5:2041731414557112
pubmed: 25610589
Brain. 2014 May;137(Pt 5):1454-69
pubmed: 24625696
Br J Dermatol. 2019 Apr;180(4):849-858
pubmed: 30291626
Mucosal Immunol. 2019 Mar;12(2):545-554
pubmed: 30617300
Blood. 2000 Sep 1;96(5):1681-4
pubmed: 10961863
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Immunity. 2014 Nov 20;41(5):694-707
pubmed: 25517612
Ageing Res Rev. 2004 Apr;3(2):233-47
pubmed: 15177057
J Leukoc Biol. 2006 Feb;79(2):303-11
pubmed: 16330528
Blood. 2000 Jul 15;96(2):719-26
pubmed: 10887140
Nat Rev Drug Discov. 2020 Apr;19(4):253-275
pubmed: 31969717
Open Biol. 2012 Nov;2(11):120134
pubmed: 23226600

Auteurs

Anna Barkaway (A)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Loïc Rolas (L)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Régis Joulia (R)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Jennifer Bodkin (J)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Tchern Lenn (T)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Charlotte Owen-Woods (C)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Natalia Reglero-Real (N)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Monja Stein (M)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Laura Vázquez-Martínez (L)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Tamara Girbl (T)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Robin N Poston (RN)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Matthew Golding (M)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Rebecca S Saleeb (RS)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Aude Thiriot (A)

Department of Immunology and HMS Center for Immune Imaging, Harvard Medical School, Boston, MA, MA 02115, USA; The Ragon Institute of MGH, MIT and Harvard, Cambridge MA 02139, USA.

Ulrich H von Andrian (UH)

Department of Immunology and HMS Center for Immune Imaging, Harvard Medical School, Boston, MA, MA 02115, USA; The Ragon Institute of MGH, MIT and Harvard, Cambridge MA 02139, USA.

Johan Duchene (J)

Institute for Cardiovascular Prevention (IPEK), Ludwig-Maximillians-Universität (LMU) München, Munich 80336, Germany.

Mathieu-Benoit Voisin (MB)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Cleo L Bishop (CL)

Centre for Cell Biology and Cutaneous Research, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.

David Voehringer (D)

Department of Infection Biology, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen 91054, Germany.

Axel Roers (A)

Institute for Immunology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden 01069, Germany.

Antal Rot (A)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Centre for Inflammation and Therapeutic Innovation, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK.

Tim Lämmermann (T)

Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.

Sussan Nourshargh (S)

Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK; Centre for Inflammation and Therapeutic Innovation, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. Electronic address: s.nourshargh@qmul.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH